Menopause Treatment Reduces Alzheimer's Risk
A large Stanford study found that women who used estrogen-only menopausal hormone therapy had a 35% lower likelihood of Alzheimer’s-related brain changes and a 39% reduction in dementia risk. The research analyzed post-mortem brain data from over 21,000 women and suggested that hormone therapy, particularly when started around menopause, may confer neuroprotective benefits. While the findings support estrogen’s potential role in reducing Alzheimer’s pathology, the study emphasizes the need for further clinical trials to confirm these results.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)